Skip to main content
. 2022 May 6;14(5):1002. doi: 10.3390/pharmaceutics14051002

Figure 3.

Figure 3

Overview of the DiI-labelled exosomes (DiI-U87 exo, DiI-U87-Selu exo, DiI-A549 exo and DiI-A549-Selu exo) in vivo targeting experiments.